ArticleOphthalmology science2023

Phase I NT-501 Ciliary Neurotrophic Factor Implant Trial for Primary Open-Angle Glaucoma: Safety, Neuroprotection, and Neuroenhancement.

Jeffrey L Goldberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.